Ms. Wang focuses her legal practice on patent and technology transactions. She mainly serves technology companies, especially those in the fields of pharmaceutical, biotechnology, chemistry and chemical engineering. She represents clients in patent invalidation and infringement litigation. As a legal counsel to a number of biopharmaceutical companies, she helps the clients with patent strategy development, enterprise IP system establishment, patent prosecution, and provides clients with patent validity analysis, FTO analysis, and other patent-related matters. Ms. Wang had managed a series of European patent opposition and appeal cases between Novozymes and its competitors, and participated in licensing negotiations to settle Novozymes’ global IP disputes. Ms. Wang had also worked as a team member in a plenty of R&D projects, with rich experiences in patent landscape analysis, design around and IP risk management.